21197 ⎘
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant; Organic adjuvants CpG containing adjuvants; Oligonucleotide containing adjuvants
A MONOPHOSPHORYL LIPID-A LIPOSOME BASED CANCER VACCINE
#302Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#303IMMUNOGENIC CONSTRUCTS, COMPOSITIONS, AND METHODS FOR INDUCING IMMUNE RESPONSE
#304POLYMERIC NANOVACCINES AND USES THEREOF
#305Combination Of A STING Agonist And A Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist
#306ANUCLEATE CELL-DERIVED VACCINES
#307PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND FORMULATIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES IMPACTED BY IL-6 DYSREGULATION
#308IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE
#309COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#310Combination immunotherapy for treatment of melanoma, colon or non-small cell lung cancers
#311SELF-ASSEMBLED PEPTIDE NANOPARTICLE AND USE THEREOF
#312Anti-CD55 Antibodies and Related Compositions and Methods
#313SAMRNA VACCINE AND PREPARATION METHOD THEREFOR
#314Foot-and-mouth disease vaccine
#315PEPTIDE IMMUNOGENS TARGETING CALCITONIN GENE-RELATED PEPTIDE (CGRP) AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF MIGRAINE
#316Complex for enhancing immune response
#317COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE
#318Prefusion RSV F proteins and their use
#319PREVENTING AND TREATING AMYLOID- BETA DEPOSITION BY STIMULATION OF INNATE IMMUNITY
#320IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE
#321NANOPARTICLES, CONTROLLED-RELEASE DOSAGE FORMS, AND METHODS FOR DELIVERING AN IMMUNOTHERAPEUTIC AGENT
#322DEVELOPMENT OF AN EDIBLE VACCINE
#323LYMPHANGIOGENESIS FOR THERAPEUTIC IMMUNOMODULATION
#324Anti-coronavirus vaccines
#325Rabies composition comprising PIKA adjuvant
#326IMMUNITY-INDUCING AGENT COMPRISING ANTIGEN PEPTIDE-ADJUVANT NUCLEOTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#327IMMUNOLOGICAL ADJUVANT AND VACCINE COMPOSITION INCLUDING STING AGONIST
#328Lipids and compositions for the delivery of therapeutics
#329PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE
#330Immunogenic compositions comprising polypeptides and fusions thereof
#331Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#332Pharmaceutical compositions, vaccines and their uses in the prevention or treatment of a persistent infection or of cancer
#333Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#334Compositions of Phosphorylated Tau Peptides and Uses Thereof
#335Intratumoral Alpha-Emitter Radiation and Activation of Cytoplasmatic Sensors for Intracellular Pathogen
#336Tuberculosis compositions and methods of using the same
#337METHODS OF TREATING TIM-3 ELEVATION
#338METHOD FOR MANUFACTURING A TUMOR VACCINE
#339Cell-associating immunologic adjuvants for treatment enhancement
#340TARGETING moDC TO ENHANCE VACCINE EFFICACY ON MUCOSAL SURFACE
#341Cytosolic delivery of peptides using protein transduction domain mimics
#342BIOMATERIAL-BASED COVID-19 VACCINE
#343Cancer antigens and methods
#344PEPTIDE IMMUNOGEN CONSTRUCTS DIRECTED AGAINST DIPEPTIDE REPEAT PROTEINS FROM C9ORF72
#345Immunotherapy against several tumors including neuronal and brain tumors
#346METHODS AND COMPOSITIONS COMPRISING AN NFKB INHIBITOR AND AN ADJUVANT
#347Adjuvant compositions
#348Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#349Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#350USES OF MODIFIED RNA ENCODING RETINALDEHYDE DEHYDROGENASE
#351Albumin binding peptide conjugates and methods thereof
#352HIV pre-immunization and immunotherapy
#353Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#354Boosting immunogenicity of vaccines using saponins and agonists of the intracellular stimulator of interferon genes pathway
#355COMBINATION INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A PD-1 ANTAGONIST FOR TREATING BREAST CANCER
#356Methods and devices for the treatment of food allergies
#357Intranasal vaccine that induces cellular immunity
#358MICROCAPSULE-BASED VACCINE
#359Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
#360BACTERICIDAL/PERMEABILITY INCREASING PROTEIN FOR USE IN A METHOD OF IMMUNIZATION, PREFERABLY AS AN ADJUVANT IN A METHOD OF VACCINATION
#361Stimulator of Interferon Genes (STING) ligands and uses thereof
#362NOVEL TH1-INDUCING ADJUVANT COMPRISING COMBINATION OF DIFFERENT NUCLEIC ACID ADJUVANTS, AND USE OF SAME
#363VACCINATION WITH MICA/B ALPHA 3 DOMAIN FOR THE TREATMENT OF CANCER
#364TRITERPENE SAPONIN ANALOGUES
#365NEOANTIGENS AND USES THEREOF
#366Heroin vaccine
#367Immunotherapy against several tumors including neuronal and brain tumors
#368Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#369COMPOSITIONS AND METHODS FOR TREATING SECONDARY TUBERCULOSIS AND NONTUBERCULOUS MYCOBACTERIUM INFECTIONS
#370Immunotherapy against several tumors including neuronal and brain tumors
#371ANTI-TUMOR COMPOSITIONS AND USES THEREOF
#372vaccines and uses thereof
#373Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#374Immunotherapy against several tumors including neuronal and brain tumors
#375METHODS AND COMPOSITIONS FOR TREATING CANCERS
#376Vaccine composition and uses thereof
#377COMPOSITIONS AND METHODS FOR PERSONALIZED NEOPLASIA VACCINES
#378DESIGN OF IMMUNOSTIMULATORY PROTEIN-CORE SPHERICAL NUCLEIC ACIDS
#379Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers
#380STAT3 INHIBITORS AND USES THEREOF
#381INJECTABLE CRYOGEL VACCINE DEVICES AND METHODS OF USE THEREOF
#382COMPOUNDS AND COMPOSITIONS FOR POTENTIATION OF TLR AGONISTS
#383OLIGONUCLEOTIDE CONSTRUCTS AND USES THEREOF
#384Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer
#385Dendritic gold nanoparticles and methods of synthesis
#386VACCINE ADJUVANTS
#387Vaccine compositions
#388Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof
#389Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
#390Immunostimulatory compositions
#391Oil-based adjuvants
#392Pathogen vaccines and methods of producing and using the same
#393NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#394MDR immunogen
#395Immunostimulatory compositions, particles, and uses related thereto
#396Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#397Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#398Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#399PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND FORMULATIONS THEREOF FOR TREATMENT OF SYNUCLEINOPATHIES
#400Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#401Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#402IMMUNOMODULATORY THERAPEUTIC MRNA COMPOSITIONS ENCODING ACTIVATING ONCOGENE MUTATION PEPTIDES
#403VACCINE COMPOSITION
#404Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#405Methods and compositions for substance use disorder vaccine formulations and uses thereof
#406CD200 inhibitors and methods of use thereof
#407Compositions and methods for delivery of biomacromolecule agents
#408Tau peptide immunogen constructs
#409Stabilized Soluble Pre-Fusion RSV F Polypeptides
#410METHODS FOR THE STIMULATION OF DENDRITIC CELL (DC) PRECURSOR POPULATION "PRE-DC" AND THEIR USES THEREOF
#411RECOMBINANT FUSION PROTEIN AND IMMUNOGENIC COMPOSITION
#412Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#413REGULATABLE CHIMERIC ANTIGEN RECEPTOR
#414COMPOSITION AND THERAPEUTIC ANTI-TUMOUR VACCINE
#415Medicament for use in a method of inducing or extending a cellular cytotoxic immune response
#416Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#417IMMUNOSTIMULATORY OLIGONUCLEOTIDES
#418Compounds including a mutant KRAS sequence and a lipid and uses thereof
#419Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#420Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#421Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#422Methods and compositions for treating cancers using antisense
#423METHOD FOR IMPROVING THE EFFICACY OF A SURVIVIN VACCINE IN THE TREATMENT OF CANCER
#424Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#425Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#426Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#427Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#428METHODS FOR TREATING HPV-ASSOCIATED DISEASES
#429Scaffolded HIV-1 Env GP140 trimer immunogen
#430MODIFIED CYCLIC DINUCLEOTIDE COMPOUNDS
#431Compositions and methods for vaccination against respiratory syncytial virus infection
#432Coccidioides antigens and methods of their use
#433Vaccine delivery method
#434Immunotherapeutic constructs and methods of their use
#435VACCINES AGAINST HENDRA AND NIPAH VIRUS INFECTION
#436Lipid nanoparticle vaccine adjuvants and antigen delivery systems
#437POLYMER ADJUVANT
#438Pro-inflammatory and anti-cancer functions of toll-like receptor 4 antagonists
#439Pro-inflammatory and adjuvant functions of toll-like receptor 4 antagonists
#440NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE
#441Immunostimulatory oligonucleotides
#442Structure-Function Relationships in the Development of Immunotherapeutic Agents
#443SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#444Compositions of phosphorylated tau peptides and uses thereof
#445IMMUNE-ENHANCING RNAS FOR COMBINATION WITH CHIMERIC ANTIGEN RECEPTOR THERAPY
#446Vaccine delivery systems using yeast cell wall particles
#447Molecular adjuvant and vaccine
#448Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#449Compositions for stimulation of mammalian innate immune resistance to pathogens
#450Whole-cell tumor vaccine based on principle of extracellular trap and method of making same
#451Heterologous administration of tau vaccines
#452Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis
#453Vaccines comprising polypeptides for the prevention, treatment, and diagnosis of leprosy
#454Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus Vectors
#455Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#456Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#457Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#458Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#459Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#460Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#461Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#462Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#463Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#464Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#465Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#466Delivery of biomolecules to PBMCs to modify an immune response
#467DNA VACCINES AND METHODS FOR THE PREVENTION OF TRANSPLANTATION REJECTION
#468Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#469Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#470Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#471Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#472Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#473Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#474COMPOSITIONS AND METHODS FOR ACTIVATING "STIMULATOR OF INTERFERON GENE"-DEPENDENT SIGNALLING
#475Peptide vaccines and pembrolizumab for treating breast cancer
#476Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling
#477Combination vaccine devices and methods of killing cancer cells
#478Amphiphilic oligodeoxynucleotide conjugates as adjuvant enhancers
#479Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#480Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#481Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#482Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#483RNA CONTAINING COMPOSITIONS AND METHODS OF THEIR USE
#484Vaccine adjuvant comprising lipopeptide-inserted liposome as effective ingredient and use thereof
#485Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#486Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#487Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#488Method of safe administration of phosphorylated tau peptide vaccine
#489Synthetic conjugate of CpG DNA and T-help/CTL peptide
#490Nanoparticles for treatment of allergy
#491Anti-OX40 antibodies and uses thereof
#492Methods of treating a retroviral infection
#493Immunogenic proteins against
#494Combination immunotherapy dosing regimen for immune checkpoint blockade
#495Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#496Compositions and methods for antigen targeting to CD180
#497COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE
#498Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#499Methods and compositions for stimulating immune response
#500Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#501Tuberculosis compositions and methods of treating or preventing tuberculosis
#502Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#503Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#504Attenuated porcine sapelovirus strain and immunogenic compositions therefrom
#505RSV F protein compositions and method for making same
#506Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#507Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#508Modified virus-like particles of CMV
#509Particles comprising a shell with RNA
#510Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#511Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#512Compositions and Methods for Treating Secondary Tuberculosis and Nontuberculosis Mycobacterium Infections
#513Hydrogel delivery of sting immunotherapy for treatment cancer
#514Methods and devices for the treatment of food allergies
#515Complexes for delivery of antigenic peptides
#516MEDICAL TREATMENT METHOD WITH ADMINISTRATION OF DENDRITIC CELLS
#517RESPIRATORY SYNCYTIAL VIRUS (RSV) POLYANHYDRIDE NANOPARTICLE VACCINE
#518IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC INFORMATION
#519METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF
#520HIV pre-immunization and immunotherapy
#521Methods and compositions relating to adjuvants
#522Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#523Immunoglobulin single variable domain antibody against RSV prefusion F protein
#524Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant
#525Adoptive cell therapy using spherical nucleic acids (SNAs)
#526Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#527Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
#528PROTEIN NANOPARTICLES AND COMBINATION THERAPY FOR CANCER IMMUNOTHERAPY
#529Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#530Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#531Foot-and-mouth disease vaccine
#532MESOTHELIN VACCINE FOR OVARIAN CANCER PREVENTION
#533Bacterial membrane nanoparticles as an immunotherapy system for cancer treatment
#534Compositions and methods for enhancing innate immunity in a subject for treatment of infections and cancer and other acute and chronic conditions of the eye
#535Vaccine delivery systems using yeast cell wall particles
#536Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
#537IMMUNOGENIC COMPOSITION COMPRISING SURVIVIN PEPTIDES
#538SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS
#539Protection against recurrent genital herpes by therapeutic immunization with herpes simplex virus type 2 ribonucleotide reductase protein subunits
#540Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#541Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
#542Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#543Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#544Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#545Financial Method
#546RNA-based compositions and adjuvants for prophylactic and therapeutic treatment
#547IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS
#548Recombinant HIV-1 envelope proteins and their use
#549Increased fertility in bovine species
#550COMPOSITIONS AND METHODS FOR DELIVERY OF POLYMER/BIOMACROMOLECULE CONJUGATES
#551Methods and compositions for treating cancers using antisense
#552FcRn-targeted mucosal vaccination against influenza infections
#553Use of nanoparticles for immunotherapy
#554IMMUNOMODULATORY THERAPEUTIC MRNA COMPOSITIONS ENCODING ACTIVATING ONCOGENE MUTATION PEPTIDES
#555Nicotine nanovaccines and uses thereof
#556Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles
#557Recombinant prefusion RSV F proteins and uses thereof
#558Eimeria vaccine with improved efficacy
#559Preventing and treating amyloid-beta deposition by stimulation of innate immunity
#560Immunotherapy against melanoma and other cancers
#561Immunotherapy against melanoma and other cancers
#562Tuberculosis compositions and methods of using the same
#563COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#564Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
#565Functional influenza virus like particles (VLPs)
#5665′-triphosphate oligoribonucleotides
#567Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
#568IPSC-based vaccine as a prophylactic and therapeutic treatment for cancer
#569Adjuvant compositions
#570SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#571Chlamydia antigens
#572Methods and compositions for inducing an immune response
#573FHSS hotspot device and methods
#574Methods and compositions for adaptive immune modulation
#575Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#576Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#577Vaccine composition
#578Interferon Therapy
#579Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#580Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#581Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#582Chimeric norovirus P particle and preparation and use thereof
#583Branched chimeric compounds, and methods of use thereof
#584Vaccine against infectious bronchitis
#585ANTI-OPIOID VACCINES
#586Vaccine composition
#587Vaccine delivery systems using yeast cell wall particles
#588Vaccine composition comprising cyclic peptides, antibodies to the cyclic peptides or an anticancer composition comprising the same
#589Guanosine as an Immune Potentiator Mediated through Toll Receptors
#590HIV pre-immunization and immunotherapy
#591ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF
#592Biomaterials for modulating immune responses
#593HIV pre-immunization and immunotherapy
#594Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
#595Enhanced immunogenicity of mRNA with co-encoded adjuvant sequences
#596PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES
#597Immunomodulatory therapeutic MRNA compositions encoding activating oncogene mutation peptides
#598Lipids and compositions for the delivery of therapeutics
#599Methods and compositions for treating cancer
#600Compositions and methods for activating antigen presenting cells with chimeric poliovirus